Related Experiment Videos
Preparation of transparent injectable formulation for lipid A analog E5531
1Formulation Research Laboratory, Kawashima, Eisai Company, Limited, Gifu, Japan.
Drug Development and Industrial Pharmacy
|October 13, 1999
Summary
A novel pH-jump method effectively creates transparent, injectable E5531 solutions at neutral pH. This technique enhances pharmaceutical formulation by avoiding mechanical power and ensuring stability.
Area of Science:
- Pharmaceutical Science
- Biophysical Chemistry
Background:
- E5531, a synthetic lipid A analog, requires specific formulation for pharmaceutical injection.
- Solubility challenges exist for E5531 at neutral pH due to its pKa values.
Purpose of the Study:
- To develop a method for preparing transparent, neutral pH solutions of E5531.
- To optimize E5531 formulation for pharmaceutical applications.
Main Methods:
- A pH-jump method was developed, utilizing E5531's dissociation at high pH (11.0) and its phase transition temperature (Tc = 30°C).
- E5531 was dispersed at pH 11.0 and 50°C, then neutralized with a phosphate buffer.
- Differential scanning calorimetry (DSC) was used to determine Tc.
Main Results:
- The pH-jump method yielded transparent E5531 solutions with low turbidity, comparable to water.
- No degradation products were observed after 3 hours at 50°C in alkaline solution.
- The method requires no mechanical power and is scalable.
Conclusions:
- The pH-jump method is a viable and efficient technique for producing stable, injectable E5531 formulations.
- This approach overcomes solubility issues and is suitable for large-scale pharmaceutical production.